Insider Selling at Exact Sciences (EXAS) Continues with Significant Sale

Friday, November 03, 2017 10:15 PM ET

Insider Selling at Exact Sciences (EXAS) Continues with Significant Sale

One insider — Dr Graham Peter Lidgard, Officer — today, disposed of 45,775 shares of Exact Sciences having a market value of approximately $2,453,768, as indicated in a form 4 document filed with the SEC. There have been 2 insiders with buy/sell transactions in the past 90 days prior to this filing. These trades have resulted in the acquisition of 2,500 company shares and the sale of 45,775 company shares over this time period. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 89,050 shares and have averaged 31,350 shares per transaction over this time period.

Over the last 90 days, the number of insider buy/sell trades at Exact Sciences is higher than its 185-company peer group average. The Biotechnology & Medical Research peer group saw 211 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Exact Sciences insiders is lower than its peers. Within the peer group there were 23,152,301 shares purchased and 51,386,307 shares sold with company insiders selling 133,810 shares on average over this time period.

The data obtained in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.